ExCEEd Orphan
PrivateLast Round
Strategic
Aug 1, 2022
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ExCEEd Orphan is a biopharmaceutical services company that provides market access, regulatory, and commercialization solutions for rare disease treatments in Central and Eastern Europe.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Compliance, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ExCEEd Orphan Comparables
Compare ExCEEd Orphan with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avanzanite Bioscience | 85% | |
| Swixx BioPharma | 79% | |
| Partner Rare | 78% |
ExCEEd Orphan Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Aug 1, 2022 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 32% MoM.
- Jun 19, 2026
Monthly visitors increased 109% MoM.
ExCEEd Orphan Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ExCEEd Orphan's valuation, stock price, and market status.
Is ExCEEd Orphan a public or private company?
ExCEEd Orphan is a private company.
What is the current stock price of ExCEEd Orphan?
ExCEEd Orphan is a private company with no public stock price. No recent secondary market data is available.
How much is ExCEEd Orphan worth (valuation)?
Valuation information for ExCEEd Orphan is not publicly available.
Can I buy ExCEEd Orphan stock?
ExCEEd Orphan shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ExCEEd Orphan's last funding round?
ExCEEd Orphan's most recent funding round was Strategic on August 1, 2022.
Who are the main investors in ExCEEd Orphan?
Investor information for ExCEEd Orphan is not publicly disclosed.
Will ExCEEd Orphan IPO soon?
No public IPO plans have been announced for ExCEEd Orphan.
How can I track ExCEEd Orphan secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ExCEEd Orphan's secondary market activity and sign up for updates.